6-K ·Filed May 4, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor the Q1 2026 earnings release on May 11 for financial performance and any updates on pipeline programs. The lack of a conference call may limit immediate market reaction.
Final — all horizons settled through T+60d
CLLS ▼ -24.20% at T+60d
NEUTRAL call -24.20% · α vs SPY -26.94% · entry $3.76 → $2.85
T+1d
+5.05%
call +5.05% · α +3.67%
$3.95
settled 6mo ago
T+5d
+5.32%
call +5.32% · α +3.33%
$3.96
settled 6mo ago
T+20d
-10.11%
call -10.11% · α -15.06%
$3.38
settled 5mo ago
T+60d
-24.20%
call -24.20% · α -26.94%
$2.85
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Cellectis announced it will report Q1 2026 financial results on May 11, 2026 after market close, with no conference call. This is a routine earnings date notification with no preliminary financial data.
Key Facts
- Q1 2026 earnings release scheduled for May 11, 2026 after US market close
- No conference call will be held; investor relations available via email
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- No material risk identified from this filing
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
85% bullish (13 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-002982 |
| Exhibit: exh_991.htm | 0001171843-26-002982 |
| Document: 0001171843-26-002982-index-headers.html | 0001171843-26-002982 |
| Document: 0001171843-26-002982-index.html | 0001171843-26-002982 |
| Document: 0001171843-26-002982.txt | 0001171843-26-002982 |
14 reports for CLLS
40% Hit rate @ T+60 Went positive at some point 4 of 6 best @ T+20▲ +35.52%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 6w ago | 6-K | $1.83 | awaiting T+60 | — | $0.9670 (+47.16%) |
Sep 11, 2026 6w ago | Press Release | $1.83 | awaiting T+60 | — | $0.9670 (−47.16%) |
Aug 6, 2026 11w ago | Press Release | $2.84 | awaiting T+60 | — | $0.9670 (−65.89%) |
Jun 29, 2026 17w ago | Court Ruling | $3.00 $1.43 | ▼ −52.33% | ▼ −55.32% | $0.9670 (−67.77%) |
Jun 25, 2026 17w ago | 6-K | $2.83 $1.51 | ▼ −46.64% | ▼ −52.75% | $0.9670 (−65.83%) |
Jun 25, 2026 17w ago | 6-K | $2.83 $1.51 | ▼ −46.64% | ▼ −52.75% | $0.9670 (−65.83%) |
Jun 11, 2026 19w ago | Press Release | $3.09 $3.24 | ▲ +4.85% | ▲ +0.46% | $0.9670 (−68.71%) |
Jun 9, 2026 19w ago | 6-K | $3.18 $3.32 | ▲ +4.40% | ▼ −2.18% | $0.9670 (−69.59%) |
May 12, 2026 23w ago | 6-K | $3.96 $2.69 | ▼ −32.07% | ▼ −36.45% | $0.9670 (−75.58%) |
May 4, 2026 25w ago | 6-K | $3.76 $2.85 | ▼ −24.20% | ▼ −26.94% | $0.9670 (−74.28%) |
Showing 10 of 14
US Market Status
Market Closed — Opens in 3h 53m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers